(Q43941189)

English

High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Plasmodium falciparum

0 references

pregnancy-associated malaria

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

human pregnancy

1 reference

based on heuristic

inferred from title

pregnant person

1 reference

based on heuristic

inferred from title

Justin Doritchamou

object named as

Justin Doritchamou

3

0 references

Christentze Schmiegelow

object named as

Christentze Schmiegelow

6

0 references

Nicaise Tuikue Ndam

object named as

Nicaise Tuikue Ndam

4

0 references

object named as

Ali Salanti

14

0 references

Morten Agertoug Nielsen

object named as

Morten A Nielsen

15

0 references

Thor G. Theander

object named as

Thor G Theander

13

0 references

Achille Massougbodji

7

object named as

Achille Massougbodji

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Pamela Magistrado

1

object named as

Pamela A Magistrado

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

12

object named as

John Lusingu

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Daniel Minja

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Davis John

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Madeleine Dahlbäck

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sisse B Ditlev

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Vera V Pinto

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mafalda Resende

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

12 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

437-443

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Changes in the Levels of Chemokines and Cytokines in the Placentas of Women withPlasmodium falciparumMalaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Maternal antibodies block malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Maternal malaria and parasite adhesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

High level of var2csa transcription by Plasmodium falciparum isolated from the placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Transcribed var genes associated with placental malaria in Malawian women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Structural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Relationship Between Altitude and Intensity of Malaria Transmission in the Usambara Mountains, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

A simple perfusion technique for isolation of maternal intervillous blood mononuclear cells from human placentae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Human malaria parasites in continuous culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Separation of malaria-infected erythrocytes from whole blood: use of a selective high-gradient magnetic separation technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Role of nonimmune IgG bound to PfEMP1 in placental malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

The RTS,S malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

The problem of malaria and malaria control in pregnancy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.080

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.10.080

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43941189&oldid=2104539046"